Anti-SOCS3 Purified

Anti-SOCS3 Purified
Regulatory status
RUO
Antigen
SOCS3
Clone
SO1
Format
Purified
Reactivity
Human
Application
Variant
0.1 mg
11-406-C100
In stock
198.00 USD

0.025 mg
11-406-C025
Delivery 1 week
99.00 USD
Variant
0.1 mg
11-406-C100
In stock
198.00 USD

0.025 mg
11-406-C025
Delivery 1 week
99.00 USD
Product details
Description
Images
References
SDS download
Isotype
Mouse IgG2b
Specificity
The antibody SO1 reacts with SOCS3, an intracellular cytokine signaling inhibitor.
Application
Application details
Western blotting: Positive control: HeLa human cervix carcinoma cell line, reducing conditions.
Reactivity
Human
Immunogen
Full-length SOCS3 protein.
Concentration
1 mg/ml
Preparation
Purified by protein-A affinity chromatography.
Formulation
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Storage and handling
Store at 2-8°C. Do not freeze.
Exbio licence note
The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.
Other names
SOCS-3, CIS3, SSI3
Antigen description
SOCS3 (suppressor of cytokine signaling 3), also known as CIS3 (cytokine-inducible SH2 protein 3) is a negative regulator of particular cytokine signaling pathways. SOCS3 is induced by a variety of cytokines and other stimuli, such as erythropoietin, leptin and lipopolysaccharides and inhibits tyrosinkinase activity of JAK kinases, or e.g. JNK phosphorylation. SOCS3 modulates cytokine-mediated and neoplastic-proliferative responses and is involved also in maintaining leukocytes in quiescent state until antigen stimulation.
Entrez Gene ID 9021
UniProt ID Q6FI39
11-406 WB
Western blotting analysis (reducing conditions) of whole cell lysate of HeLa human cervix carcinoma cell line. Lane 1: immunostaining with Isotype mouse IgG2b control (PLRV219; cat. no. 11-801-C100) Lane 2: immunostaining with anti-SOCS3 (SO1)

General references:

Miao T, Wu D, Zhang Y, Bo X, Xiao F, Zhang X, Magoulas C, Subang MC, Wang P, Richardson PM: SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase. Mol Cell Neurosci. 2008 Feb;37(2):367-75.
PubMed
Elliott J: SOCS3 in Liver Regeneration and Hepatocarcinoma. Mol Interv. 2008 Feb;8(1):19-21.
PubMed
Zhu BM, Ishida Y, Robinson GW, Pacher-Zavisin M, Yoshimura A, Murphy PM, Hennighausen L. SOCS3 Negatively Regulates the gp130-STAT3 Pathway in Mouse Skin Wound Healing. J Invest Dermatol. 2008 Jan 10
PubMed
Kimura A, Kinjyo I, Matsumura Y, Mori H, Mashima R, Harada M, Chien KR, Yasukawa H, Yoshimura A. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem. 2004 Feb 20;279(8):6905-10.
PubMed
Yu CR, Mahdi RM, Ebong S, Vistica BP, Gery I, Egwuagu CE: Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J Biol Chem. 2003 Aug 8;278(32):29752-9.
PubMed

Product specific references:

Neuwirt H, Puhr M, Cavarretta IT, Mitterberger M, Hobisch A, Culig Z: Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion. Endocr Relat Cancer. 2007 Dec;14(4):1007-19.
PubMed
Variant
0.1 mg
11-406-C100
In stock
198.00 USD

0.025 mg
11-406-C025
Delivery 1 week
99.00 USD
Variant
0.1 mg
11-406-C100
In stock
198.00 USD

0.025 mg
11-406-C025
Delivery 1 week
99.00 USD